Epigenetics projected to be $5B market by end of 2018.

With companies striving to push their drugs and diagnostic technologies for several oncological indications, the competition in the global epigenetics drugs and diagnostics technologies market is likely to intensify over the next couple of years, says Transparency Market Research (TMR) in a research report. The global market for epigenetics drugs and diagnostic technologies is expected to register significant growth during the forecast period. The report projected to rise to a valuation of $5.7 billion by the end of 2018.

Read Full Article

Posted in